STOCK TITAN
  1. Home
  2. Sec-filings
  3. INCY
  4. [144] INCYTE CORP SEC Filing

Incyte (NASDAQ: INCY) plans Rule 144 sale of 41,899 shares worth 5.0M

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Incyte Corporation is registering a planned resale of common stock under Rule 144. The filing covers 41,899 common shares, with an aggregate market value of 5,005,186.06, proposed to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ on or after July 31, 2026. The shares include 39,712 shares acquired from the issuer via stock option exercises for cash on July 31, 2026 and 2,187 shares acquired as restricted stock from the issuer on July 15, 2026.

Positive

  • None.

Negative

  • None.
Shares covered 41,899 shares Common shares subject to planned Rule 144 resale
Aggregate market value 5,005,186.06 Aggregate market value of 41,899 common shares
Stock option exercise shares 39,712 shares Common shares acquired from issuer via stock option exercise on 07/31/2026
Restricted stock shares 2,187 shares Common shares acquired as restricted stock from issuer on 07/15/2026
Proposed sale date 07/31/2026 Approximate date of sale on NASDAQ
Rule 144 regulatory
"registering a planned resale of common stock under Rule 144"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Stock Option Exercise financial
"acquired from the issuer via stock option exercises for cash"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
Restricted Stock financial
"acquired as restricted stock from the issuer on July 15, 2026"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
aggregate market value financial
"with an aggregate market value of 5,005,186.06"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does Incyte (INCY) disclose in this Rule 144 filing?
Incyte discloses a planned resale of 41,899 common shares under Rule 144, with an aggregate market value of 5,005,186.06, to be sold through Morgan Stanley Smith Barney LLC on NASDAQ on or after July 31, 2026.

How many Incyte (INCY) shares are tied to stock option exercises?
The filing identifies 39,712 common shares acquired from the issuer via stock option exercise on July 31, 2026, for cash consideration, as part of the securities that may be sold under Rule 144.

How many restricted stock shares of Incyte (INCY) are included?
The Rule 144 notice includes 2,187 common shares that were acquired as restricted stock from the issuer on July 15, 2026, which are part of the shares that may be resold.

What is the aggregate market value of Incyte (INCY) shares covered?
The planned Rule 144 resale covers common shares with an aggregate market value of 5,005,186.06, based on the figures reported for the 41,899 shares identified in the notice.

Through which broker and market will Incyte (INCY) shares be sold?
The shares may be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ market, with an anticipated sale date of July 31, 2026, as stated in the filing.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR